Morgan Stanley & Co. Int'l plc Rule 38.5 -Replacement of ALLERGAN PLC (7095X)
December 20 2019 - 8:52AM
UK Regulatory
TIDM48QN TIDM0Y7T
RNS Number : 7095X
Morgan Stanley & Co. Int'l plc
20 December 2019
AMENDMENT Section (2a)
FORM 38.5
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 38.5 OF THE IRISH TAKEOVER PANEL ACT,
1997, TAKEOVER RULES, 2007 (AS AMENDED)
DEALINGS BY CONNECTED EXEMPT MARKET-MAKERS
1. KEY INFORMATION
Name of exempt market-maker Morgan Stanley & Co. International
plc
Company dealt in ALLERGAN PLC
------------------------------------
Class of relevant security to US$0.0001 ORDINARY SHARES
which the dealings being disclosed
relate (Note 1)
------------------------------------
Date of dealing 18 DECEMBER 2019
------------------------------------
2. DEALINGS (Note 2)
(a) Purchases and sales
Total number of relevant Highest price paid Lowest price paid (Note
secuities accquired (Note 3) 3)
20,154 190.3505 USD 190.3400 USD
------------------- ------------------------
Total number of relevant Highest price paid Lowest price paid (Note
secuities disposed (Note 3) 3)
20,154 190.3505 USD 190.3400 USD
------------------- ------------------------
(b) Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of relevant Price per unit
e.g. CFD (Note 4) securities
(Note 5)
N/A N/A N/A N/A
---------------------- ------------------- ---------------
(c) Options transactions in respect of existing relevant securities
i) Writing, selling, purchasing or varying
Product Writing, Number Exercise Type, e.g Expiry Option
name, eg selling, of securities Price American, Date money paid/received
call option purchasing, to which European per unit
varying the option etc (Note 3)
etc relates
(Note 5)
N/A N/A N/A N/A N/A N/A N/A
------------- --------------- --------- ----------- ------- ---------------------
(ii) Exercising
Product name, eg call Number of securities Exercise price per
option unit (Note 3)
N/A N/A N/A
--------------------- -------------------
3. OTHER INFORMATION
Agreements, arrangements or understandings relating to options
or derivatives
Full Details of any agreement, arrangement or understanding between
the person disclosing and any other person relating to the voting
rights of any relevant securities under any option referred to
on this form or relating to the voting rights or future acquisition
or disposal of any relevant securities to which any derivative
referred to on this form is referenced. If none, this should
be stated.
Date of disclosure 20 DECEMBER 2019
Contact Name Craig Horsley
-----------------
Telephone Number +44(141) 245 7736
-----------------
Name of offeree/offeror with ABBVIE INC.
which connected
-----------------
Nature of connection (Note 6) Advisory
-----------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
ISEPGGUAPUPBGCU
(END) Dow Jones Newswires
December 20, 2019 09:52 ET (14:52 GMT)
Allergan (LSE:0Y7T)
Historical Stock Chart
From Apr 2024 to May 2024
Allergan (LSE:0Y7T)
Historical Stock Chart
From May 2023 to May 2024
